Voyager Therapeutics, Inc.
VYGR
$3.36
$0.010.30%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.38M | -31.02M | -34.49M | -9.04M | -10.14M |
| Total Depreciation and Amortization | 1.07M | 1.01M | 1.01M | 1.13M | 1.39M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.55M | 3.93M | 2.26M | 1.56M | 5.96M |
| Change in Net Operating Assets | -5.49M | -11.81M | 16.69M | -21.62M | -28.79M |
| Cash from Operations | -33.26M | -37.90M | -14.53M | -27.97M | -31.58M |
| Capital Expenditure | -1.11M | -658.00K | -155.00K | -258.00K | -967.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.04M | 41.86M | -27.05M | 64.61M | -34.98M |
| Cash from Investing | 1.93M | 41.20M | -27.20M | 64.35M | -35.94M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 513.00K | 82.00K | 574.00K | 14.00K | 571.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 513.00K | 82.00K | 574.00K | 14.00K | 571.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.82M | 3.39M | -41.16M | 36.40M | -66.95M |